MediPal Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEPDF research report →
About the company
Medipal Holdings Corporation is a prominent player in Japan's prescription pharmaceutical wholesale sector. The company's core business involves the sourcing and distribution of a wide array of healthcare products. This includes medical equipment, materials, and clinical diagnostic reagents designed for use across the entire patient journey, from early detection of pre-symptomatic conditions through treatment and administration.
- CEO
- Shuichi Watanabe
- IPO
- 2019
- Employees
- 13,075
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $3.76B
- P/E
- 12.80
- P/S
- 0.14
- P/B
- 0.82
- EV/EBITDA
- 2.29
- Div Yield
- 2.49%
- Gross Margin
- 6.48%
- Op Margin
- 1.39%
- Net Margin
- 1.11%
- ROE
- 6.72%
- ROIC
- 4.04%
- Revenue
- $3.84T · 4.63%
- Net Income
- $42.80B · 6.27%
- EPS
- $207.71 · 7.51%
- Op Income
- $53.52B
- FCF YoY
- -16.51%
- 52W High
- $19.00
- 52W Low
- $15.90
- 50D MA
- $18.47
- 200D MA
- $17.74
- Beta
- -0.04
- Avg Volume
- 17
Get TickerSpark's AI analysis on MEPDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MEPDF coverage
Recent articles, reports, and earnings notes.
No research on MEPDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEPDF report →Similar companies
Peers in the same neighborhood.